Global Markets for Infectious Disease Treatments

Published - Jan 2016| Analyst - Peggy Lehr| Code - PHM061C
Global Markets for Infectious Disease Treatments
Single User License: $2,750 Member Price: FREE

Report Highlights

The global market for infectious disease diagnostic, vaccine, and treatment products reached $108.4 billion in 2015. The market should reach $126.2 billion in 2016 and $183.2 billion in 2021, demonstrating a compound annual growth rate (CAGR) of 7.7% from 2016 to 2021.

Report Includes

  • An overview of the global market for infectious disease treatments, with a focus on the growth in demand for newer pharmaceutical treatments, vaccines, and environmental products.
  • Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2021.
  • Discussion of the increasing concern regarding antibiotic-resistant organisms and their sometimes-fatal effects on humans.
  • Examination of technological developments, future trends, and emerging opportunities.
  • Assessments of the current state of infectious diseases on a global basis, broken down by type of disease (i.e., bacterial, viral, parasitic, and fungal) and appropriate treatments, both current and anticipated, and by geographic region.
  • A relevant patent analysis.
  • Profiles of major players in the field of infectious disease treatments.

SCOPE OF REPORT

The market report organizes information from diverse sources into a cohesive unit that includes an overview, global implications of infectious diseases, infectious diseases by type, treatment and prevention, emerging pharmaceutical and diagnostic products and an applicable patents section. Information is organized by type of infectious disease (i.e., bacterial, viral, parasitic) and appropriate treatments, both current and anticipated.

ANALYST’S CREDENTIALS

Peggy Lehr is the BCC Research analyst for this report. Ms. Lehr holds a BS in Journalism from the University of Colorado, Boulder, and an MS in Communication from the University of Denver. Ms. Lehr has worked as a researcher, editor and publisher within the publishing industry for both for-profit and not-for-profit organizations. She is the author of several BCC reports dealing with healthcare, pharmaceuticals and agriculture. Her latest report, BIO145A The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments was published in Aug. 2015.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - May-2013| Analyst - Peggy Lehr| Code - PHM061B

Report Highlights

The global market for infectious disease diagnostic, vaccine and pharmaceutical products was $59.2 billion in 2011 and $66.4 billion in 2012.  Market growth looks promising, the overall market value for 2017 is projected to be $96.8 billion after increasing at a compound annual growth rate (CAGR) of 7.8%.

Report Includes

  • An overview of the global market for infectious disease treatments, with a focus on the growth in demand for newer pharmaceutical treatments, vaccines, and environmental products
  • Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017
  • Discussion of the increasing concern regarding antibiotic-resistant organisms and their sometimes-fatal effects on humans
  • Examination of technological developments, future trends, and emerging opportunities
  • Assessments of the current state of infectious diseases on a global basis, broken down by type of disease (i.e., bacterial, viral, parasitic, and fungal) and appropriate treatments, both current and anticipated, and by geographic region
  • Patent analysis
  • Comprehensive company profiles of major players.

Published - Apr-2010| Analyst - Peggy Lehr| Code - PHM061A

Report Highlights

  • The global market for infectious disease treatments was valued at $90.4 billion in 2009. This market is expected to increase at a compound annual growth rate (CAGR) of 8.8% to reach $138 billion in 2014.
  • The largest market share belongs to antibiotic treatments for bacterial and fungal diseases at 53% of the total infectious disease treatment market.  Fungal disease treatments will experience a slightly higher compound annual growth rate (CAGR) of 6.2%, from $4.6 billion in 2009 to $6.2 billion in 2014.
  • Viral disease treatments will have the fastest compound annual growth rate (CAGR) of 12.1%, increasing from nearly $45 billion in 2009 to $79 billion in 2014.
RELATED REPORTS
Share This Report